Cargando…

Knockdown of METTL14 suppresses the malignant progression of non-small cell lung cancer by reducing Twist expression

Non-small cell lung cancer (NSCLC) is one of the most malignant cancer types. N6-methyladenosine (m6A), an abundant eukaryotic mRNA modification, has been observed in multiple diseases, particularly cancer. Methyltransferase-like 14 (METTL14) is a central component of the m6A methyltransferase compl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Fang, Yuan, Wei-Qi, Li, Juan, Luo, Yi-Qin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561617/ https://www.ncbi.nlm.nih.gov/pubmed/34733365 http://dx.doi.org/10.3892/ol.2021.13108

Ejemplares similares

Knockdown of METTL14 inhibits the growth and invasion of cervical cancer
por: Geng, Feng, et al.
Publicado: (2019)

The molecular mechanism of METTL3 promoting the malignant progression of lung cancer
por: Ma, Chao, et al.
Publicado: (2022)

Knockdown of RAI14 suppresses the progression of gastric cancer
por: Chen, Cheng, et al.
Publicado: (2018)

Analysis of METTL3 and METTL14 in hepatocellular carcinoma
por: Liu, Xiangxiang, et al.
Publicado: (2020)

Novel insights into the METTL3-METTL14 complex in musculoskeletal diseases
por: Xu, Yeqiu, et al.
Publicado: (2023)

Knockdown of CHPF suppresses cell progression of non-small-cell lung cancer
por: Hou, Xiao-Ming, et al.
Publicado: (2019)

METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA
por: Meng, Liping, et al.
Publicado: (2022)

Insights into roles of METTL14 in tumors
por: Liu, Xin, et al.
Publicado: (2021)

The Distinct Function and Localization of METTL3/METTL14 and METTL16 Enzymes in Cardiomyocytes
por: Arcidiacono, Orazio Angelo, et al.
Publicado: (2020)

Correction: Novel insights into the METTL3-METTL14 complex in musculoskeletal diseases
por: Xu, Yeqiu, et al.
Publicado: (2023)

A cryptic pocket in METTL3-METTL14 regulates m(6)A conversion and sensing
por: Qi, Shan, et al.
Publicado: (2023)

Knockdown of METTL16 disrupts learning and memory by reducing the stability of MAT2A mRNA
por: Zhang, Runjiao, et al.
Publicado: (2022)

Knockdown of m6A methyltransferase METTL3 in gastric cancer cells results in suppression of cell proliferation
por: Jiang, Li, et al.
Publicado: (2020)

Solution structure of the RNA recognition domain of METTL3-METTL14 N(6)-methyladenosine methyltransferase
por: Huang, Jinbo, et al.
Publicado: (2018)

METTL14 Suppresses CRC Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 Processing
por: Chen, Xiaoxiang, et al.
Publicado: (2020)

RNA binding to human METTL3-METTL14 restricts N(6)-deoxyadenosine methylation of DNA in vitro
por: Qi, Shan, et al.
Publicado: (2022)

HIV Replication Is Increased by RNA Methylation METTL3/METTL14/WTAP Complex Activators
por: Selberg, Simona, et al.
Publicado: (2021)

Roles of the m6A methyltransferases METTL3, METTL14, and WTAP in pulmonary tuberculosis
por: Zhang, Tian-Ping, et al.
Publicado: (2022)

The Comprehensive Analysis of N6-Methyadenosine Writer METTL3 and METTL14 in Gastric Cancer
por: Ge, Yiling, et al.
Publicado: (2023)

N6-Methyladenosine Methyltransferase METTL14-Mediated Autophagy in Malignant Development of Oral Squamous Cell Carcinoma
por: Wang, Fang, et al.
Publicado: (2021)

METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS
por: Chen, Jie-Xun, et al.
Publicado: (2023)

Knockdown of SUMO-activating enzyme subunit 2 (SAE2) suppresses cancer malignancy and enhances chemotherapy sensitivity in small cell lung cancer
por: Liu, Xiaoke, et al.
Publicado: (2015)

Knockdown of POLE2 expression suppresses lung adenocarcinoma cell malignant phenotypes in vitro
por: Li, Jianying, et al.
Publicado: (2018)

The RNA Methyltransferase Complex of WTAP, METTL3, and METTL14 Regulates Mitotic Clonal Expansion in Adipogenesis
por: Kobayashi, Masatoshi, et al.
Publicado: (2018)

Interactions, localization, and phosphorylation of the m(6)A generating METTL3–METTL14–WTAP complex
por: Schöller, Eva, et al.
Publicado: (2018)

Knockdown of lncRNA CCEPR suppresses colorectal cancer progression
por: Duan, Yuxia, et al.
Publicado: (2019)

Targeting METTL14 and RNA methylation to treat osteosarcoma
por: Ren, Lili, et al.
Publicado: (2022)

Retraction Notice to: METTL14 Suppresses CRC Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 Processing
por: Chen, Xiaoxiang, et al.
Publicado: (2022)

piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner
por: Xie, Qi, et al.
Publicado: (2022)

A METTL3-METTL14 complex mediates mammalian nuclear RNA N(6)-adenosine methylation
por: Liu, Jianzhao, et al.
Publicado: (2013)

DDX5/METTL3-METTL14/YTHDF2 Axis Regulates Replication of Influenza A Virus
por: Zhao, Lingcai, et al.
Publicado: (2022)

Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling
por: Huang, Miao-Juei, et al.
Publicado: (2015)

Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression
por: Zhang, Yunwen, et al.
Publicado: (2023)

Knockdown of CDCA5 suppresses malignant progression of breast cancer cells by regulating PDS5A
por: Wang, Yang, et al.
Publicado: (2022)

miR186 suppresses prostate cancer progression by targeting Twist1
por: Zhao, Xian, et al.
Publicado: (2016)

The study of METTL3 and METTL14 expressions in childhood ETV6/RUNX1‐positive acute lymphoblastic leukemia
por: Sun, Congcong, et al.
Publicado: (2019)

METTL14 suppresses cancer stem cell phenotype of colorectal cancer via regulating of β-catenin/NANOG
por: Sun, Chun-Lei, et al.
Publicado: (2023)

Functions, mechanisms, and therapeutic implications of METTL14 in human cancer
por: Guan, Qian, et al.
Publicado: (2022)

METTL14-mediated RNA methylation in digestive system tumors
por: Hu, Jiexuan, et al.
Publicado: (2023)

METTL14 aggravates podocyte injury and glomerulopathy progression through N(6)-methyladenosine-dependent downregulating of Sirt1
por: Lu, Zhihui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_06u6mpubj0a8t4caou4j5patbl